Canlyniadau Chwilio - Tremblay, Gabriel

US Budget Impact Model for Selinexor, Bortezomib, and Dexamethasone for the Treatment of Previously Treated Multiple Myeloma gan Dolph, Mike, Tremblay, Gabriel, Leong, Hoyee

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cost Effectiveness of Triplet Selinexor-Bortezomib-Dexamethasone (XVd) in Previously Treated Multiple Myeloma (MM) Based on Results from the Phase III BOSTON Trial gan Dolph, Michael, Tremblay, Gabriel, Leong, Hoyee

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Comparative Effectiveness of Remestemcel-L-rknd versus Ruxolitinib in Pediatric Patients with Steroid-Refractory Acute Graft-Versus-Host Disease using Simulated Treatment Compariso... gan Tremblay, Gabriel, Tomaras, Dimitrios, Strati, Eric, Forsythe, Anna

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Network Meta-Analysis of Once Weekly Selinexor-Bortezomib-Dexamethasone in Previously Treated Multiple Myeloma gan Dolph, Michael, Tremblay, Gabriel, Gilligan, Adrienne M, Leong, Hoyee

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory... gan Tremblay, Gabriel, Livings, Christopher, Crowe, Lydia, Kapetanakis, Venediktos, Briggs, Andrew

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cost-effectiveness analysis for midostaurin versus standard of care in acute myeloid leukemia in the United Kingdom gan Tremblay, Gabriel, Dolph, Mike, Patel, Sachin, Brandt, Patricia, Forsythe, Anna

Cael y testun llawn Cael y testun llawn Cael y testun llawn

HIGHLY METHYL ESTERIFIED SEEDS Is a Pectin Methyl Esterase Involved in Embryo Development gan Levesque-Tremblay, Gabriel, Müller, Kerstin, Mansfield, Shawn D., Haughn, George W.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea gan Tremblay, Gabriel, Majethia, Unnati, Breeze, Janis L, Kontoudis, Ilias, Park, Jeongae

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Progression-free survival/time to progression as a potential surrogate for overall survival in HR+, HER2− metastatic breast cancer gan Forsythe, Anna, Chandiwana, David, Barth, Janina, Thabane, Marroon, Baeck, Johan, Tremblay, Gabriel

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Matching-adjusted indirect treatment comparison of ribociclib and palbociclib in HR+, HER2− advanced breast cancer gan Tremblay, Gabriel, Chandiwana, David, Dolph, Mike, Hearnden, Jaclyn, Forsythe, Anna, Monaco, Mauricio

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia gan Tremblay, Gabriel, Dolph, Mike, Bhor, Menaka, Said, Qayyim, Elliott, Brian, Briggs, Andrew

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cost-Effectiveness Analysis of a HMGA2 Prognostic Test for Acute Myeloid Leukemia in a Canadian Setting gan Tremblay, Gabriel, Rousseau, Ben, Marquis, Miriam, Beaubois, Cyrielle, Sauvageau, Guy, Hébert, Josée

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Humanistic and Economic Burden of Conversion Therapy Among LGBTQ Youths in the United States gan Forsythe, Anna, Pick, Casey, Tremblay, Gabriel, Malaviya, Shreena, Green, Amy, Sandman, Karen

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Improving access to antiretrovirals in China: economic analyses of dolutegravir in HIV-1 patients gan Punekar, Yogesh Suresh, Guo, Na, Tremblay, Gabriel, Piercy, James, Holbrook, Tim, Young, Benjamin

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Systematic review of health state utility values for acute myeloid leukemia gan Forsythe, Anna, Brandt, Patricia S, Dolph, Mike, Patel, Sachin, Rabe, Adrian Paul J, Tremblay, Gabriel

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Is progression-free survival a more relevant endpoint than overall survival in first-line HR+/HER2− metastatic breast cancer? gan Forsythe, Anna, Chandiwana, David, Barth, Janina, Thabane, Marroon, Baeck, Johan, Shor, Anastasiya, Tremblay, Gabriel

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia gan Tremblay, Gabriel, Dolph, Mike, Bhor, Menaka, Said, Qayyim, Roy, Anuja, Elliott, Brian, Briggs, Andrew

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Indirect treatment comparisons including network meta-analysis: Lenvatinib plus everolimus for the second-line treatment of advanced/metastatic renal cell carcinoma gan Tremblay, Gabriel, McElroy, Heather J., Westley, Tracy, Meier, Genevieve, Misurski, Derek, Guo, Matthew

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Overexpression of a pectin methylesterase inhibitor in Arabidopsis thaliana leads to altered growth morphology of the stem and defective organ separation gan Müller, Kerstin, Levesque-Tremblay, Gabriel, Fernandes, Anwesha, Wormit, Alexandra, Bartels, Sebastian, Usadel, Bjoern, Kermode, Allison

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Overall survival of glasdegib in combination with low-dose cytarabine, azacitidine, and decitabine among adult patients with previously untreated AML: comparative effectiveness usi... gan Tremblay, Gabriel, Westley, Tracy, Cappelleri, Joseph C, Arondekar, Bhakti, Chan, Geoffrey, Bell, Timothy J, Briggs, Andrew

Cael y testun llawn Cael y testun llawn Cael y testun llawn